Luis Gómez Carrera

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Experimental Vibrio harveyi infections in Penaeus vannamei larvae

P. Riley M. Robertson, J. Calderón, Luis Gómez Carrera et al. · Diseases of Aquatic Organisms · 1998 · 114 citations · Full text

Biology, Parasitic Disease, Marine Biotechnology +15

Future of biotechnology-based control of disease in marine invertebrates.

Eric Mialhe, Evelyne Bachère, Viviane Boulo et al. · PubMed · 1995 · 33 citations

Engineering, Pathogen Detection, Microbial Pathogens +16

Use of modular megaprosthesis in managing chronic end-stage periprosthetic hip and knee infections: Is there an increase in relapse rate?

Pablo S. Corona, Matías Vicente, Mireia Lalanza et al. · European Journal of Orthopaedic Surgery & Traumatology · 2018 · 32 citations

Regenerative Medicine, Hip Arthroplasty, Relapse Rate +13

Increased infection risk after hip hemiarthroplasty in institutionalized patients with proximal femur fracture

Irene Gallardo‐Calero, Thais Larrainzar-Coghen, Dolors Rodríguez-Pardo et al. · Injury · 2016 · 30 citations

Skeletal Trauma, Institutionalized Patients, Infection Risk +9